2022 World Conference on Lung Cancer (ePosters)-EP08.01-110. Trial in Progress: A Phase 2 Multicenter Study (IOV-LUN-202) of Autologous Tumor-infiltrating Lymphocyte (TIL) Cell Therapy (LN-145) in mNSCLC

EP08.01-110. Trial in Progress: A Phase 2 Multicenter Study (IOV-LUN-202) of Autologous Tumor-infiltrating Lymphocyte (TIL) Cell Therapy (LN-145) in mNSCLC

Back to course

Pdf Summary

Summary Not Available

Asset Subtitle

Jason Alan Chesney

Meta Tag

Speaker Jason Alan Chesney

Topic Metastatic Non-small Cell Lung Cancer - Immunotherapy